DDInter360 DDInter1082
A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Chlorothiazide {u} (Compound) resembles {v} (Compound) Hydroflumethiazide
Chlorothiazide {u} (Compound) resembles {v} (Compound) Cyclothiazide
Chlorothiazide {u} (Compound) treats {v} (Disease) hypertension
Chlorothiazide {u} (Compound) binds {v} (Gene) CA2
Chlorothiazide {u} (Compound) upregulates {v} (Gene) TICAM1
Chlorothiazide {u} (Compound) is included by {v} (Pharmacologic Class) Increased Diuresis
Chlorothiazide {u} (Compound) causes {v} (Side Effect) Nephritis interstitial
Chlorothiazide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Propantheline
Chlorothiazide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Minocycline
Chlorothiazide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Salbutamol
Chlorothiazide (Compound) resembles Hydroflumethiazide (Compound)
Chlorothiazide (Compound) resembles Cyclothiazide (Compound)
Chlorothiazide (Compound) treats hypertension (Disease)
Chlorothiazide (Compound) binds CA2 (Gene)
Chlorothiazide (Compound) upregulates TICAM1 (Gene)
Chlorothiazide (Compound) is included by Increased Diuresis (Pharmacologic Class)
Chlorothiazide (Compound) causes Nephritis interstitial (Side Effect)
Chlorothiazide may cause a minor interaction that can limit clinical effects when taken with Propantheline
Chlorothiazide may cause a minor interaction that can limit clinical effects when taken with Minocycline
Chlorothiazide may cause a moderate interaction that could exacerbate diseases when taken with Salbutamol